Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0AH1B
|
||||
Former ID |
DNC004699
|
||||
Drug Name |
3-[4-Methyl-indan-(1Z)-ylidenemethyl]-pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527456] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H15N
|
||||
Canonical SMILES |
CC1=CC=CC2=C1CCC2=CC3=CN=CC=C3
|
||||
InChI |
1S/C16H15N/c1-12-4-2-6-16-14(7-8-15(12)16)10-13-5-3-9-17-11-13/h2-6,9-11H,7-8H2,1H3/b14-10-
|
||||
InChIKey |
ORCOWTSQEFCEFC-UVTDQMKNSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [527456] | |
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen Metabolism | ||||
Reactome | Endogenous sterols | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.